VYNE Therapeutics Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of VYNE for the last quarter is 121.00 k USD, and it's 38.89% lower compared to the previous quarter. The net income of Q3 24 is -12.16 M USD.